1. RPT-000374 Data on File MA 12414 – Report of Prior Clinical Investigations DUROLANE.
  2. DUROLANE Product Insert: 3ML (Dec. 2013) and SJ 1ML (Dec. 2013).
  3. Plaas A, Li J, Riesco J, Das R, Sandy JD, Harrison A. Intraarticular injection of hyaluronan prevents cartilage erosion, periarticular fibrosis and mechanical allodynia and normalizes stance time in murine knee osteoarthritis. Arthritis Res Ther. 2011;13(2):R46.
  4. Boettger MK, Kümmel D, Harrison A, Schaible HG. ‘Evaluation Of Long-Term Antinociceptive Properties Of Stabilized Hyaluronic Acid Preparation (NASHA) In An Animal Model Of Repetitive Joint Pain’. Arthritis Research & Therapy. 2011; 13.4: R110.
  5. Early Detection for OA. Arthritis Foundation Web site. http://www. arthritistoday.org/about-arthritis/types-of-arthritis/osteoarthritis/what-you-needto-know/biochemical-markers.php. Published 2015. Accessed January 28, 2015.
  6. American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum.2000;43(9):1905­1915.
  7. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3­9.
  8. Agerup B, Berg P, Åkermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs. 2005;19(1):23-30.
  9. Krocker D, Matziolis G, Tuischer J, et al. Reduction of arthrosis associated knee pain through a single intraarticular injection of synthetic hyaluronic acid. Z Rheumatol. 2006; 65(4):327-31.
  10. Edsman K, Melin H, Näsström J. A study of the ability of DUROLANE to withstand degradation by free radicals while maintaining its viscoelastic properties. Poster presented at: 55th Annual Meeting of the Orthopaedic Research Society; February 2009; Las Vegas, NV.
  11. Åkermark C, Berg P, Björkman A, Malm P. Non-Animal Stabilised Hyaluronic Acid in the Treatment of Osteoarthritis of the Knee A Tolerability Study. Clin Drug Invest 2002; 22 (3): 157-166.
  12. McGrath A, McGrath AM, Jessop ZM, et al. A Comparison of Intra-Articular Hyaluronic Acid Competitors in the Treatment of Mild to Moderate Knee Osteoarthritis. J Arthritis. 2013;2:1.
  13. Leighton R, Åkermark C, Therrien R, et al. NASHA hyaluronic acid vs methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial.Osteoarthritis Cartilage. 2014; 22: 17-25.
  14. Lindqvist U, Tolmachev V, Kairemo K, et al. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet. 2002;41(8):603-613.
  15. Larsen NE, Dursema HD, Pollak CT, Skrabut EM. Clearance kinetics of a hylan-based viscosupplement after intra-articular and intravenous administration in animal models. J Biomed Mater Res B Appl Biomater. 2012; 100(2):457-466.
  16. Brown TJ, Laurent UB, Fraser JR. Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol. 1991; 76(1):125-134.
  17. Edsman K, Hjelm R, Lärkner H, et al. Intra-articular Duration of DUROLANE after Single Injection into the Rabbit Knee. Cartilage. 2011; 2(4) 384–388.
  18. Hunter DJ, Felson DT. Osteoarthritis. BMJ. 2006 18;332(7542): 639- 42.
  19. Hinton R, Moody RL, Davis AW, Thomas SF. Osteoarthritis: Diagnosis and Therapeutic Considerations. Am Fam Physician. 2002;65(5):841-849.
  20. Wooley P, Song Z, Harrison A. Evaluation of the Biocompatibility of DUROLANE using the Murine Air Pouch Model. Poster presented at: 55th Annual Meeting of the Orthopaedic Research Society; February 2009; Las Vegas, NV.
  21. Berg P, Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol.2004;22(3):300-6.
  22. Conrozier T, Couris CM, Mathieu P, et al. Safety, efficacy and predictive factors of efficacy of a single intraarticular injection of non-animal-stabilized-hyaluronicacid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. Arch Orthop Trauma Surg (2009) 129:843–848.
  23. Altman RD, Åkermark C, Beaulieu AD, Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. OsteoArthritis and Cartilage. 2004; 12:642-649.
  24. Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162(1):46-54.